Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 50,793 |
|
|||||
| News | - | ||||||
| Day High | 1.99 | Low High |
|||||
| Day Low | 1.93 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.02 | -1.02% | 1.94 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.95 | 1.93 | 1.99 | 1.94 | 1.96 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 560 | 50,793 | US$ 1.95 | US$ 99,197 | - | 1.11 - 3.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:03:51 | formt | 973 | US$ 1.98 | USD |
ProQR Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 157.83M | 81.35M | - | 6.59M | -28.12M | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProQR Therapeutics NV News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/15/2024 | 06:46 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2/14/2024 | 05:08 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/09/2024 | 05:37 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/19/2024 | 06:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 1/05/2024 | 06:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 11/07/2023 | 09:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 9/27/2023 | 06:06 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 9/14/2023 | 16:20 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 8/03/2023 | 06:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 8/01/2023 | 06:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRQR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.90 | 2.12 | 1.84 | 1.99 | 141,591 | 0.04 | 2.11% |
| 1 Month | 2.26 | 2.46 | 1.81 | 2.09 | 165,543 | -0.32 | -14.16% |
| 3 Months | 2.17 | 2.70 | 1.81 | 2.13 | 207,739 | -0.23 | -10.60% |
| 6 Months | 1.23 | 3.29 | 1.11 | 2.05 | 261,652 | 0.71 | 57.72% |
| 1 Year | 2.24 | 3.29 | 1.11 | 1.87 | 264,241 | -0.30 | -13.39% |
| 3 Years | 6.18 | 9.09 | 0.53 | 2.83 | 809,861 | -4.24 | -68.61% |
| 5 Years | 11.23 | 13.28 | 0.53 | 4.52 | 744,825 | -9.29 | -82.72% |
ProQR Therapeutics NV Description
| ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. |
